{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:07:58Z","timestamp":1791256078595,"version":"4.1.0"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05909-6","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:34:37Z","timestamp":1778589277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["From Molecular Networks to Medicines: Targeting Complexity in Alzheimer\u2019s Disease (AD) Therapy"],"prefix":"10.1007","volume":"63","author":[{"given":"Rahul","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem Shankar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriyansh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathvik Belagodu","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javedh","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif Bin","family":"Muhsinah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"5909_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199444","author":"AV Ivanova","year":"2025","unstructured":"Ivanova AV, Kutuzova AD, Kuzmichev IA, Abakumov MA (2025) Alzheimer\u2019s disease: from molecular mechanisms to promising therapeutic strategies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26199444","journal-title":"Int J Mol Sci"},{"issue":"13","key":"5909_CR2","doi-asserted-by":"publisher","first-page":"9193","DOI":"10.1021\/acs.jmedchem.2c00399","volume":"65","author":"K Lu","year":"2022","unstructured":"Lu K et al (2022) Rational design of a theranostic agent triggered by endogenous nitric oxide in a cellular model of Alzheimer\u2019s disease. J Med Chem 65(13):9193\u20139205. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00399","journal-title":"J Med Chem"},{"key":"5909_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12061256","author":"EG Guzm\u00e1n-L\u00f3pez","year":"2023","unstructured":"Guzm\u00e1n-L\u00f3pez EG, Reina M, Hern\u00e1ndez-Ayala LF, Galano A (2023) Rational design of multifunctional ferulic acid derivatives aimed for Alzheimer\u2019s and Parkinson\u2019s diseases. Antioxidants Basel. https:\/\/doi.org\/10.3390\/antiox12061256","journal-title":"Antioxidants Basel"},{"key":"5909_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biology12071019","author":"MA Sultana","year":"2023","unstructured":"Sultana MA, Hia RA, Akinsiku O, Hegde V (2023) Peripheral mitochondrial dysfunction: a potential contributor to the development of metabolic disorders and Alzheimer\u2019s disease. Biology Basel. https:\/\/doi.org\/10.3390\/biology12071019","journal-title":"Biology Basel"},{"key":"5909_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jdad2020017","author":"AE Alkhalifa","year":"2025","unstructured":"Alkhalifa AE, Alkhalifa O, Durdanovic I, Ibrahim DR, Maragkou S (2025) Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease: insights into pathophysiology and treatment. Journal of Dementia and Alzheimer\u2019s Disease. https:\/\/doi.org\/10.3390\/jdad2020017","journal-title":"Journal of Dementia and Alzheimer's Disease"},{"issue":"2","key":"5909_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11065-023-09584-5","volume":"34","author":"C Xiang","year":"2024","unstructured":"Xiang C, Zhang Y (2024) Comparison of cognitive intervention strategies for individuals with Alzheimer\u2019s disease: a systematic review and network meta-analysis. Neuropsychol Rev 34(2):402\u2013416. https:\/\/doi.org\/10.1007\/s11065-023-09584-5","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"5909_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10367","volume":"8","author":"P Chopade","year":"2023","unstructured":"Chopade P, Chopade N, Zhao Z, Mitragotri S, Liao R, Chandran Suja V (2023) Alzheimer\u2019s and Parkinson\u2019s disease therapies in the clinic. Bioeng Transl Med 8(1):e10367","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"5909_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02753-6","volume":"20","author":"M Wang","year":"2023","unstructured":"Wang M, Zhang H, Liang J, Huang J, Chen N (2023) Exercise suppresses neuroinflammation for alleviating Alzheimer\u2019s disease. J Neuroinflammation 20(1):76. https:\/\/doi.org\/10.1186\/s12974-023-02753-6","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5909_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.18632\/aging.203826","volume":"14","author":"C-C Hung","year":"2022","unstructured":"Hung C-C, Chang C-C, Huang C-W, Nouchi R, Cheng C-H (2022) Gut microbiota in patients with Alzheimer\u2019s disease spectrum: a systematic review and meta-analysis. Aging 14(1):477\u2013496. https:\/\/doi.org\/10.18632\/aging.203826","journal-title":"Aging"},{"issue":"5","key":"5909_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka MT et al (2025) Neuroinflammation in Alzheimer disease. Nat Rev Immunol 25(5):321\u2013352. https:\/\/doi.org\/10.1038\/s41577-024-01104-7","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"5909_CR11","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1021\/acs.jmedchem.2c00335","volume":"65","author":"D Padhi","year":"2022","unstructured":"Padhi D, Govindaraju T (2022) Mechanistic insights for drug repurposing and the design of hybrid drugs for Alzheimer\u2019s disease. J Med Chem 65(10):7088\u20137105. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00335","journal-title":"J Med Chem"},{"key":"5909_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091353","author":"FR Buccellato","year":"2021","unstructured":"Buccellato FR, D\u2019Anca M, Fenoglio C, Scarpini E, Galimberti D (2021) Role of oxidative damage in Alzheimer\u2019s disease and neurodegeneration: from pathogenic mechanisms to biomarker discovery. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10091353","journal-title":"Antioxidants"},{"key":"5909_CR13","doi-asserted-by":"publisher","unstructured":"Rahman A, Jaiswal A, Keshari P, Singh DK (2025) \u201cAlzheimer\u2019s: epidemiology, pathophysiology, diagnosis, and treatments BT - Proteostasis: investigating molecular dynamics in neurodegenerative disorders,\u201d N. Puranik, Ed., Singapore: Springer Nature Singapore, pp. 39\u201372. https:\/\/doi.org\/10.1007\/978-981-96-6202-9_2.","DOI":"10.1007\/978-981-96-6202-9_2"},{"issue":"21","key":"5909_CR14","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","volume":"15","author":"R Tenchov","year":"2024","unstructured":"Tenchov R, Sasso JM, Zhou QA (2024) Alzheimer\u2019s disease: exploring the landscape of cognitive decline. ACS Chem Neurosci 15(21):3800\u20133827. https:\/\/doi.org\/10.1021\/acschemneuro.4c00339","journal-title":"ACS Chem Neurosci"},{"key":"5909_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010884","author":"G Bivona","year":"2023","unstructured":"Bivona G et al (2023) Microglial activation and priming in Alzheimer\u2019s disease: state of the art and future perspectives. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010884","journal-title":"Int J Mol Sci"},{"key":"5909_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914794","author":"KS Orobets","year":"2023","unstructured":"Orobets KS, Karamyshev AL (2023) Amyloid precursor protein and Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241914794","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5909_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00854-9","volume":"20","author":"J Xiang","year":"2025","unstructured":"Xiang J et al (2025) Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition. Mol Neurodegener 20(1):60. https:\/\/doi.org\/10.1186\/s13024-025-00854-9","journal-title":"Mol Neurodegener"},{"key":"5909_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1450998","volume":"15","author":"J Guo","year":"2024","unstructured":"Guo J et al (2024) Unravelling oncosis: morphological and molecular insights into a unique cell death pathway. Front Immunol 15:1450998","journal-title":"Front Immunol"},{"key":"5909_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12028-025-02226-z","volume":"43","author":"D Qi","year":"2025","unstructured":"Qi D, Wei P, Cui Y, Lenahan C, Tao X, Jin P (2025) Inhibition of C3a\/C3aR by SB290157 attenuates neuroinflammation via PKC\/P38\/NLRP3 signaling pathway after intracerebral hemorrhage. Neurocrit Care 43:44\u201358. https:\/\/doi.org\/10.1007\/s12028-025-02226-z","journal-title":"Neurocrit Care"},{"issue":"1","key":"5909_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s10565-025-10057-z","volume":"41","author":"Y Li","year":"2025","unstructured":"Li Y et al (2025) From neurotoxicity to neuroprotection: rethinking GABAAR-targeting anesthetics. Cell Biol Toxicol 41(1):104","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"5909_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70015","volume":"10","author":"S Weninger","year":"2024","unstructured":"Weninger S et al (2024) Alzheimer\u2019s disease drug development in an evolving therapeutic landscape. Alzheimers Dement N Y 10(4):e70015","journal-title":"Alzheimers Dement N Y"},{"key":"5909_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136901","author":"MK Singh","year":"2024","unstructured":"Singh MK, Shin Y, Ju S, Han S, Kim SS, Kang I (2024) Comprehensive overview of Alzheimer\u2019s disease: etiological insights and degradation strategies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25136901","journal-title":"Int J Mol Sci"},{"key":"5909_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13071513","author":"D Krawczuk","year":"2025","unstructured":"Krawczuk D, Kulczy\u0144ska-Przybik A, Mroczko B (2025) The potential regulators of amyloidogenic pathway of APP processing in Alzheimer\u2019s disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13071513","journal-title":"Biomedicines"},{"key":"5909_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032092","author":"M Kim","year":"2023","unstructured":"Kim M, Bezprozvanny I (2023) Analysis of non-amyloidogenic mutations in APP supports loss of function hypothesis of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032092","journal-title":"Int J Mol Sci"},{"key":"5909_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612964","author":"R Coronel","year":"2023","unstructured":"Coronel R et al (2023) Amyloid precursor protein (APP) regulates gliogenesis and neurogenesis of human neural stem cells by several signaling pathways. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241612964","journal-title":"Int J Mol Sci"},{"issue":"20","key":"5909_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203201","volume":"11","author":"F Jiao","year":"2022","unstructured":"Jiao F, Jiang D, Li Y, Mei J, Wang Q, Li X (2022) Amyloidogenesis and neurotrophic dysfunction in Alzheimer\u2019s disease: do they have a common regulating pathway? Cells 11(20):3201. https:\/\/doi.org\/10.3390\/cells11203201","journal-title":"Cells"},{"issue":"1","key":"5909_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A (2024) The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states. Mol Brain 17(1):44. https:\/\/doi.org\/10.1186\/s13041-024-01118-1","journal-title":"Mol Brain"},{"key":"5909_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112841","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5909_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00518-y","volume":"17","author":"G Zhang","year":"2022","unstructured":"Zhang G et al (2022) Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer\u2019s disease. Mol Neurodegener 17(1):12. https:\/\/doi.org\/10.1186\/s13024-022-00518-y","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5909_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/cm.21782","volume":"81","author":"GS Bloom","year":"2024","unstructured":"Bloom GS, Norambuena A (2024) Dysregulation of mTOR by tau in Alzheimer\u2019s disease. Cytoskeleton 81(1):30\u201334","journal-title":"Cytoskeleton"},{"issue":"1","key":"5909_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01504-w","volume":"16","author":"S Sirisi","year":"2024","unstructured":"Sirisi S, S\u00e1nchez-Aced \u00c9, Belbin O, Lle\u00f3 A (2024) APP dyshomeostasis in the pathogenesis of Alzheimer\u2019s disease: implications for current drug targets. Alzheimers Res Ther 16(1):144. https:\/\/doi.org\/10.1186\/s13195-024-01504-w","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"5909_CR32","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","volume":"28","author":"N Basheer","year":"2023","unstructured":"Basheer N et al (2023) Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials. Mol Psychiatry 28(6):2197\u20132214","journal-title":"Mol Psychiatry"},{"issue":"11","key":"5909_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11112167","volume":"11","author":"MC Jurc\u0103u","year":"2022","unstructured":"Jurc\u0103u MC et al (2022) The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives. Antioxidants 11(11):2167. https:\/\/doi.org\/10.3390\/antiox11112167","journal-title":"Antioxidants"},{"issue":"1","key":"5909_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","volume":"19","author":"T Ashleigh","year":"2023","unstructured":"Ashleigh T, Swerdlow RH, Beal MF (2023) The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis. Alzheimers Dement 19(1):333\u2013342","journal-title":"Alzheimers Dement"},{"key":"5909_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081628","author":"G Plascencia-Villa","year":"2023","unstructured":"Plascencia-Villa G, Perry G (2023) Roles of oxidative stress in synaptic dysfunction and neuronal cell death in Alzheimer\u2019s disease. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12081628","journal-title":"Antioxidants"},{"issue":"1","key":"5909_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-09021-z","volume":"51","author":"R Dhapola","year":"2024","unstructured":"Dhapola R, Beura SK, Sharma P, Singh SK, HariKrishnaReddy D (2024) Oxidative stress in Alzheimer\u2019s disease: current knowledge of signaling pathways and therapeutics. Mol Biol Rep 51(1):48. https:\/\/doi.org\/10.1007\/s11033-023-09021-z","journal-title":"Mol Biol Rep"},{"issue":"3","key":"5909_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17(3):157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"key":"5909_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041636","author":"A G\u00f3mez Morillas","year":"2021","unstructured":"G\u00f3mez Morillas A, Besson VC, Lerouet D (2021) Microglia and neuroinflammation: what place for P2RY12? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22041636","journal-title":"Int J Mol Sci"},{"issue":"21","key":"5909_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112990","volume":"23","author":"S Merighi","year":"2022","unstructured":"Merighi S, Nigro M, Travagli A, Gessi S (2022) Microglia and Alzheimer\u2019s disease. Int J Mol Sci 23(21):12990. https:\/\/doi.org\/10.3390\/ijms232112990","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5909_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","volume":"19","author":"M Tzioras","year":"2023","unstructured":"Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL (2023) Synaptic degeneration in Alzheimer disease. Nat Rev Neurol 19(1):19\u201338. https:\/\/doi.org\/10.1038\/s41582-022-00749-z","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"5909_CR41","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.14336\/AD.2019.1125","volume":"11","author":"KY Wong","year":"2020","unstructured":"Wong KY, Roy J, Fung ML, Heng BC, Zhang C, Lim LW (2020) Relationships between mitochondrial dysfunction and neurotransmission failure in Alzheimer\u2019s disease. Aging Dis 11(5):1291\u20131316. https:\/\/doi.org\/10.14336\/AD.2019.1125","journal-title":"Aging Dis"},{"key":"5909_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216288","author":"AE Alkhalifa","year":"2023","unstructured":"Alkhalifa AE, Al-Ghraiybah NF, Odum J, Shunnarah JG, Austin N, Kaddoumi A (2023) Blood\u2013brain barrier breakdown in Alzheimer\u2019s disease: mechanisms and targeted strategies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242216288","journal-title":"Int J Mol Sci"},{"issue":"14","key":"5909_CR43","doi-asserted-by":"publisher","first-page":"11459","DOI":"10.1021\/acs.jmedchem.4c01347","volume":"67","author":"C Ma","year":"2024","unstructured":"Ma C, Lindsley CW, Chang J, Yu B (2024) Rational molecular editing: a new paradigm in drug discovery. J Med Chem 67(14):11459\u201311466. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01347","journal-title":"J Med Chem"},{"issue":"1","key":"5909_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s41983-024-00908-7","volume":"60","author":"S Jain","year":"2024","unstructured":"Jain S, Chauhan N (2024) Exploring non-canonical targets in Alzheimer\u2019s disease: a departure from the norm. Egypt J Neurol Psychiatry Neurosurg 60(1):135. https:\/\/doi.org\/10.1186\/s41983-024-00908-7","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"5909_CR45","doi-asserted-by":"crossref","unstructured":"Albertini C, Salerno A, de Sena Murteira Pinheiro P, Bolognesi ML (2021) From combinations to multitarget\u2010directed ligands: a continuum in Alzheimer\u2019s disease polypharmacology. Med Res Rev 41(5):2606\u20132633","DOI":"10.1002\/med.21699"},{"key":"5909_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26185441","author":"E Uliassi","year":"2021","unstructured":"Uliassi E, de Oliveira AS, de Camargo Nascente L, Romeiro LAS, Bolognesi ML (2021) Cashew nut shell liquid (CNSL) as a source of drugs for Alzheimer\u2019s disease. Molecules. https:\/\/doi.org\/10.3390\/molecules26185441","journal-title":"Molecules"},{"key":"5909_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.853180","volume":"14","author":"A Sayad","year":"2022","unstructured":"Sayad A et al (2022) The emerging roles of the \u03b2-secretase BACE1 and the long non-coding RNA BACE1-AS in human diseases: a focus on neurodegenerative diseases and cancer. Front Aging Neurosci 14:853180","journal-title":"Front Aging Neurosci"},{"key":"5909_CR48","doi-asserted-by":"crossref","unstructured":"Nelson VK, Jha NK, Nuli MV, Gupta S, Kanna S, Gahtani RM, Hani U, Singh AK, Abomughaid MM, Abomughayedh AM, Almutary AG (2024) Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications. Ageing research reviews.Jul 1;98:102224","DOI":"10.1016\/j.arr.2024.102224"},{"key":"5909_CR49","doi-asserted-by":"crossref","unstructured":"McGroarty J, Salinas S, Evans H, Jimenez B, Tran V, Kadavakollu S, Vashist A, Atluri V (2025) Inflammasome-mediated neuroinflammation: A key driver in Alzheimer\u2019s disease pathogenesis. Biomolecules. May 7;15(5):676.","DOI":"10.3390\/biom15050676"},{"issue":"4","key":"5909_CR50","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s13105-024-01052-9","volume":"80","author":"S Dobashi","year":"2024","unstructured":"Dobashi S, Yoshihara T, Ogura Y, Naito H (2024) Normobaric hypoxia accelerates high-intensity intermittent training-induced mitochondrial biogenesis (PGC-1\u03b1)-and dynamics (OPA1)-related protein expressions in rat gastrocnemius muscle. J Physiol Biochem 80(4):909\u2013917","journal-title":"J Physiol Biochem"},{"issue":"5","key":"5909_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/nu17050913","volume":"17","author":"A Zand","year":"2025","unstructured":"Zand A et al (2025) The impact of tartrazine on DNA methylation, histone deacetylation, and genomic stability in human cell lines. Nutrients 17(5):913","journal-title":"Nutrients"},{"issue":"12","key":"5909_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3310","volume":"13","author":"P Yang","year":"2023","unstructured":"Yang P et al (2023) Electroacupuncture promotes synaptic plasticity in rats with chronic inflammatory pain\u2013related depression by upregulating BDNF\/TrkB\/CREB signaling pathway. Brain Behav 13(12):e3310","journal-title":"Brain Behav"},{"key":"5909_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/biom12070996","author":"S Singh","year":"2022","unstructured":"Singh S, Yang F, Sivils A, Cegielski V, Chu X-P (2022) Amylin and secretases in the pathology and treatment of Alzheimer\u2019s disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom12070996","journal-title":"Biomolecules"},{"key":"5909_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26020388","author":"MS Wolfe","year":"2021","unstructured":"Wolfe MS (2021) Probing mechanisms and therapeutic potential of \u03b3-secretase in Alzheimer\u2019s disease. Molecules. https:\/\/doi.org\/10.3390\/molecules26020388","journal-title":"Molecules"},{"key":"5909_CR55","doi-asserted-by":"publisher","unstructured":"Swarup G, Kanik P, Shekhar V, Gupta S (2025) Chapter 11 - \u03b2- and \u03b3-secretases as therapeutic targets for Alzheimer\u2019s disease. In: Patel V, Rajput MS, Shah JS, Mehta T (eds) Targeted therapy for the central nervous system. Academic Press, pp 239\u2013263. https:\/\/doi.org\/10.1016\/B978-0-443-23841-3.00011-X","DOI":"10.1016\/B978-0-443-23841-3.00011-X"},{"issue":"1","key":"5909_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/14656566.2024.2438317","volume":"26","author":"D Antony","year":"2025","unstructured":"Antony D, Sheth P, Swenson A, Smoller C, Maguire K, Grossberg G (2025) Recent advances in Alzheimer\u2019s disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein. Expert Opin Pharmacother 26(1):63\u201373","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"5909_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00460-5","volume":"16","author":"Y Xia","year":"2021","unstructured":"Xia Y, Prokop S, Giasson BI (2021) \u2018Don\u2019t Phos Over Tau\u2019: recent developments in clinical biomarkers and therapies targeting Tau phosphorylation in Alzheimer\u2019s disease and other tauopathies. Mol Neurodegener 16(1):37. https:\/\/doi.org\/10.1186\/s13024-021-00460-5","journal-title":"Mol Neurodegener"},{"issue":"3","key":"5909_CR58","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s10571-022-01230-7","volume":"43","author":"I Aillaud","year":"2023","unstructured":"Aillaud I, Funke SA (2023) Tau aggregation inhibiting peptides as potential therapeutics for Alzheimer disease. Cell Mol Neurobiol 43(3):951\u2013961. https:\/\/doi.org\/10.1007\/s10571-022-01230-7","journal-title":"Cell Mol Neurobiol"},{"key":"5909_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084192","author":"A Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez A, Singh SK, Churruca M, Maccioni RB (2022) Alzheimer\u2019s disease and Tau self-assembly: in the search of the missing link. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23084192","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5909_CR60","doi-asserted-by":"publisher","first-page":"693","DOI":"10.7150\/ijbs.66760","volume":"18","author":"T Zhang","year":"2022","unstructured":"Zhang T et al (2022) Death-associated protein kinase 1 mediates A\u03b242 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer\u2019s disease. Int J Biol Sci 18(2):693\u2013706. https:\/\/doi.org\/10.7150\/ijbs.66760","journal-title":"Int J Biol Sci"},{"issue":"10","key":"5909_CR61","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1038\/s41380-019-0536-8","volume":"26","author":"SH Krance","year":"2021","unstructured":"Krance SH et al (2021) The complement cascade in Alzheimer\u2019s disease: a systematic review and meta-analysis. Mol Psychiatry 26(10):5532\u20135541. https:\/\/doi.org\/10.1038\/s41380-019-0536-8","journal-title":"Mol Psychiatry"},{"issue":"4","key":"5909_CR62","doi-asserted-by":"publisher","first-page":"686","DOI":"10.14283\/jpad.2023.109","volume":"10","author":"M Kiraly","year":"2023","unstructured":"Kiraly M, Foss JF, Giordano T (2023) Neuroinflammation, its role in Alzheimer\u2019s disease and therapeutic strategies. J Prev Alzheimers Dis 10(4):686\u2013698. https:\/\/doi.org\/10.14283\/jpad.2023.109","journal-title":"J Prev Alzheimers Dis"},{"issue":"10","key":"5909_CR63","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1021\/acsptsci.4c00457","volume":"7","author":"RR Doke","year":"2024","unstructured":"Doke RR, Lamkhade GJ, Vinchurkar K, Singh S (2024) Demystifying the role of neuroinflammatory mediators as biomarkers for diagnosis, prognosis, and treatment of Alzheimer\u2019s disease: a review. ACS Pharmacol Transl Sci 7(10):2987\u20133003. https:\/\/doi.org\/10.1021\/acsptsci.4c00457","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"2","key":"5909_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cns.13216","volume":"26","author":"H Kuang","year":"2020","unstructured":"Kuang H et al (2020) Exploring the bi\u2010directional relationship between autophagy and Alzheimer\u2019s disease. CNS Neurosci Ther 26(2):155\u2013166","journal-title":"CNS Neurosci Ther"},{"key":"5909_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073330","author":"M Eshraghi","year":"2021","unstructured":"Eshraghi M et al (2021) Alzheimer\u2019s disease pathogenesis: role of autophagy and mitophagy focusing in microglia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22073330","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5909_CR66","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/jnr.24781","volume":"99","author":"VK Medala","year":"2021","unstructured":"Medala VK, Gollapelli B, Dewanjee S, Ogunmokun G, Kandimalla R, Vallamkondu J (2021) Mitochondrial dysfunction, mitophagy, and role of dynamin\u2010related protein 1 in Alzheimer\u2019s disease. J Neurosci Res 99(4):1120\u20131135","journal-title":"J Neurosci Res"},{"issue":"4","key":"5909_CR67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/14728222.2021.1916469","volume":"25","author":"F Copped\u00e8","year":"2021","unstructured":"Copped\u00e8 F (2021) Epigenetic regulation in Alzheimer\u2019s disease: is it a potential therapeutic target? Expert Opin Ther Targets 25(4):283\u2013298","journal-title":"Expert Opin Ther Targets"},{"issue":"11","key":"5909_CR68","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","volume":"18","author":"L Migliore","year":"2022","unstructured":"Migliore L, Copped\u00e8 F (2022) Gene\u2013environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol 18(11):643\u2013660","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"5909_CR69","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1002\/med.21719","volume":"41","author":"K Gadhave","year":"2021","unstructured":"Gadhave K, Kumar D, Uversky VN, Giri R (2021) A multitude of signaling pathways associated with Alzheimer\u2019s disease and their roles in AD pathogenesis and therapy. Med Res Rev 41(5):2689\u20132745","journal-title":"Med Res Rev"},{"issue":"4","key":"5909_CR70","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11064-021-03227-y","volume":"46","author":"X Liu","year":"2021","unstructured":"Liu X et al (2021) Interaction of NF-\u03baB and Wnt\/\u03b2-catenin signaling pathways in Alzheimer\u2019s disease and potential active drug treatments. Neurochem. Res. 46(4):711\u2013731. https:\/\/doi.org\/10.1007\/s11064-021-03227-y","journal-title":"Neurochem. Res."},{"key":"5909_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031260","author":"K Abu-Elfotuh","year":"2025","unstructured":"Abu-Elfotuh K et al (2025) Targeting ferroptosis\/Nrf2 pathway ameliorates AlCl3-induced Alzheimer\u2019s disease in rats: neuroprotective effect of morin hydrate, zeolite clinoptilolite, and physical plus mental activities. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26031260","journal-title":"Int. J. Mol. Sci."},{"key":"5909_CR72","doi-asserted-by":"publisher","first-page":"1206572","DOI":"10.3389\/fnagi.2023.1206572","volume":"15","author":"Y Peng","year":"2023","unstructured":"Peng Y et al (2023) Current and future therapeutic strategies for Alzheimer\u2019s disease: an overview of drug development bottlenecks. Front Aging Neurosci 15:1206572","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"5909_CR73","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","volume":"29","author":"R Dhapola","year":"2021","unstructured":"Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH (2021) Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology 29(6):1669\u20131681","journal-title":"Inflammopharmacology"},{"issue":"12","key":"5909_CR74","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19(12):715\u2013736","journal-title":"Nat Rev Neurol"},{"key":"5909_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146698","author":"H Yuan","year":"2025","unstructured":"Yuan H, Zhou J, Li H, Kang S, Park S (2025) A systems biology approach to memory health: integrating network pharmacology, gut microbiota, and multi-omics for health functional foods. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26146698","journal-title":"Int. J. Mol. Sci."},{"key":"5909_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00814-7","volume":"13","author":"C Clark","year":"2021","unstructured":"Clark C, Dayon L, Masoodi M, Bowman GL, Popp J (2021) An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer\u2019s disease. Alzheimers Res Ther 13:1\u201319","journal-title":"Alzheimers Res Ther"},{"key":"5909_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint17120197","author":"JM Dong","year":"2025","unstructured":"Dong JM, Zhong H (2025) \u201cSystematic review: proteomics-driven multi-omics integration for Alzheimer\u2019s disease pathology and precision medicine,.\u201d Neurol Int. https:\/\/doi.org\/10.3390\/neurolint17120197","journal-title":"Neurol Int"},{"key":"5909_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/biom14060692","author":"P Du","year":"2024","unstructured":"Du P, Fan R, Zhang N, Wu C, Zhang Y (2024) Advances in integrated multi-omics analysis for drug-target identification. Biomolecules. https:\/\/doi.org\/10.3390\/biom14060692","journal-title":"Biomolecules"},{"key":"5909_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/biology15050410","author":"Y Ren","year":"2026","unstructured":"Ren Y, Bai H, Wang J, Yang Y, Wang Y (2026) Deep learning-enabled multi-omics integration: a new frontier in precise drug target discovery. Biology (Basel). https:\/\/doi.org\/10.3390\/biology15050410","journal-title":"Biology (Basel)"},{"issue":"4","key":"5909_CR80","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s12033-024-01133-6","volume":"67","author":"A Mukherjee","year":"2025","unstructured":"Mukherjee A, Abraham S, Singh A, Balaji S, Mukunthan KS (2025) From data to cure: a comprehensive exploration of multi-omics data analysis for targeted therapies. Mol Biotechnol 67(4):1269\u20131289. https:\/\/doi.org\/10.1007\/s12033-024-01133-6","journal-title":"Mol Biotechnol"},{"key":"5909_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12100949","author":"M Fran\u00e7ois","year":"2022","unstructured":"Fran\u00e7ois M et al (2022) \u201cMulti-omics, an integrated approach to identify novel blood biomarkers of Alzheimer\u2019s disease,.\u201d Metabolites. https:\/\/doi.org\/10.3390\/metabo12100949","journal-title":"Metabolites"},{"issue":"1","key":"5909_CR82","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13195-025-01901-9","volume":"17","author":"X Liu","year":"2025","unstructured":"Liu X, Chen J, Zhou S, Lin J (2025) Genetic insights into drug targets for Alzheimer\u2019s disease: integrative multi-omics analysis. Alzheimers Res Ther 17(1):258. https:\/\/doi.org\/10.1186\/s13195-025-01901-9","journal-title":"Alzheimers Res Ther"},{"key":"5909_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1065904","volume":"14","author":"C Clark","year":"2022","unstructured":"Clark C, Rabl M, Dayon L, Popp J (2022) \u201cThe promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer\u2019s disease,.\u201d Front Aging Neurosci 14:1065904","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"5909_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00760-w","volume":"13","author":"Y Zhou","year":"2021","unstructured":"Zhou Y et al (2021) AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer\u2019s drug discovery. Alzheimers Res Ther 13(1):24. https:\/\/doi.org\/10.1186\/s13195-020-00760-w","journal-title":"Alzheimers Res Ther"},{"key":"5909_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262010003","author":"\u00d6 Akg\u00fcller","year":"2025","unstructured":"Akg\u00fcller \u00d6, Balc\u0131 MA, Cioca G (2025) Network-medicine-guided drug repurposing for Alzheimer\u2019s disease: a multi-dimensional systems pharmacology approach. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms262010003","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5909_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-01056-z","volume":"20","author":"Y Zhai","year":"2025","unstructured":"Zhai Y et al (2025) Network pharmacology: a crucial approach in traditional Chinese medicine research. Chin Med 20(1):8. https:\/\/doi.org\/10.1186\/s13020-024-01056-z","journal-title":"Chin Med"},{"issue":"1","key":"5909_CR87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12013-025-01888-y","volume":"84","author":"M Roney","year":"2026","unstructured":"Roney M, Mohd Aluwi MFF (2026) Unraveling the systems biology of curcumin: a mini-review of its anti-diabetic potential through network pharmacology. Cell Biochem Biophys 84(1):107\u2013129. https:\/\/doi.org\/10.1007\/s12013-025-01888-y","journal-title":"Cell Biochem Biophys"},{"key":"5909_CR88","doi-asserted-by":"crossref","unstructured":"Mani S, Dubey R, Lai IC, Babu MA, Tyagi S, Swargiary G, Mody D, Singh M, Agarwal S, Iqbal D, Kumar S (2023) Oxidative stress and natural antioxidants: back and forth in the neurological mechanisms of Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease. Nov 21;96(3):877-912.","DOI":"10.3233\/JAD-220700"},{"key":"5909_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041133","author":"H Chen","year":"2023","unstructured":"Chen H et al (2023) New insights into Alzheimer\u2019s disease: novel pathogenesis, drug target and delivery. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15041133","journal-title":"Pharmaceutics"},{"issue":"1","key":"5909_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12350","volume":"8","author":"Y Zhou","year":"2022","unstructured":"Zhou Y et al (2022) The Alzheimer\u2019s Cell Atlas (TACA): a single\u2010cell molecular map for translational therapeutics accelerator in Alzheimer\u2019s disease. Alzheimers Dement N Y 8(1):e12350","journal-title":"Alzheimers Dement N Y"},{"issue":"11","key":"5909_CR91","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1080\/07391102.2024.2308756","volume":"43","author":"MA Alamri","year":"2025","unstructured":"Alamri MA, Qamar MTu (2025) Network pharmacology and molecular dynamic simulation integrated strategy for the screening of active components and mechanisms of phytochemicals from Datura innoxia on Alzheimer and cognitive decline. J Biomol Struct Dyn 43(11):5296\u20135312","journal-title":"J Biomol Struct Dyn"},{"issue":"9","key":"5909_CR92","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","volume":"25","author":"JM Tsai","year":"2024","unstructured":"Tsai JM, Nowak RP, Ebert BL, Fischer ES (2024) Targeted protein degradation: from mechanisms to clinic. Nat Rev Mol Cell Biol 25(9):740\u2013757. https:\/\/doi.org\/10.1038\/s41580-024-00729-9","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"5909_CR93","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.1080\/07391102.2023.2230279","volume":"42","author":"D Halder","year":"2024","unstructured":"Halder D, Das S, Joseph A (2024) An insight into structure-activity relationship of naturally derived biological macromolecules for the treatment of Alzheimer\u2019s disease: a review. J Biomol Struct Dyn 42(12):6455\u20136471","journal-title":"J Biomol Struct Dyn"},{"key":"5909_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030952","author":"K Ono","year":"2020","unstructured":"Ono K, Tsuji M (2020) Protofibrils of amyloid-\u03b2 are important targets of a disease-modifying approach for Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21030952","journal-title":"Int J Mol Sci"},{"key":"5909_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113630","author":"M Rodr\u00edguez-Giraldo","year":"2022","unstructured":"Rodr\u00edguez-Giraldo M, Gonz\u00e1lez-Reyes RE, Ram\u00edrez-Guerrero S, Bonilla-Trilleras CE, Guardo-Maya S, Nava-Mesa MO (2022) Astrocytes as a therapeutic target in Alzheimer\u2019s disease\u2013comprehensive review and recent developments. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232113630","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5909_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01152-2","volume":"7","author":"C Cai","year":"2022","unstructured":"Cai C, Tang Y-D, Zhai J, Zheng C (2022) The RING finger protein family in health and disease. Signal Transduct Target Ther 7(1):300. https:\/\/doi.org\/10.1038\/s41392-022-01152-2","journal-title":"Signal Transduct Target Ther"},{"key":"5909_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189987","author":"A S\u0119dzikowska","year":"2021","unstructured":"S\u0119dzikowska A, Szablewski L (2021) Insulin and insulin resistance in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22189987","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5909_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01078-9","volume":"7","author":"J Park","year":"2022","unstructured":"Park J, Lee K, Kim K, Yi S-J (2022) The role of histone modifications: from neurodevelopment to neurodiseases. Signal Transduct Target Ther 7(1):217. https:\/\/doi.org\/10.1038\/s41392-022-01078-9","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"5909_CR99","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41422-020-00464-8","volume":"31","author":"Y Fu","year":"2021","unstructured":"Fu Y et al (2021) Cartilage oligomeric matrix protein is an endogenous \u03b2-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury. Cell Res 31(7):773\u2013790. https:\/\/doi.org\/10.1038\/s41422-020-00464-8","journal-title":"Cell Res"},{"issue":"18","key":"5909_CR100","doi-asserted-by":"publisher","first-page":"2206533","DOI":"10.1002\/advs.202206533","volume":"10","author":"Z Yang","year":"2023","unstructured":"Yang Z et al (2023) Allosteric activation of transglutaminase 2 via inducing an \u2018open\u2019 conformation for osteoblast differentiation. Adv Sci 10(18):2206533","journal-title":"Adv Sci"},{"issue":"1","key":"5909_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70381-8","volume":"10","author":"X He","year":"2020","unstructured":"He X et al (2020) Zinc-mediated conformational preselection mechanism in the allosteric control of DNA binding to the zinc transcriptional regulator (ZitR). Sci Rep 10(1):13276. https:\/\/doi.org\/10.1038\/s41598-020-70381-8","journal-title":"Sci Rep"},{"issue":"14","key":"5909_CR102","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.neuron.2023.04.018","volume":"111","author":"J Rollo","year":"2023","unstructured":"Rollo J, Crawford J, Hardy J (2023) A dynamical systems approach for multiscale synthesis of Alzheimer\u2019s pathogenesis. Neuron 111(14):2126\u20132139","journal-title":"Neuron"},{"issue":"1","key":"5909_CR103","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05602-0","volume":"63","author":"ZM Hein","year":"2025","unstructured":"Hein ZM et al (2025) \u201cToward a unified framework in molecular neurobiology of Alzheimer\u2019s disease: revisiting the pathophysiological hypotheses,.\u201d Mol Neurobiol 63(1):282. https:\/\/doi.org\/10.1007\/s12035-025-05602-0","journal-title":"Mol Neurobiol"},{"key":"5909_CR104","doi-asserted-by":"publisher","unstructured":"Cruchaga C\u00a0et al (2024)\u00a0Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer\u2019s disease.\u00a0Res Sq.\u00a0https:\/\/doi.org\/10.21203\/rs.3.rs-3631708\/v1.","DOI":"10.21203\/rs.3.rs-3631708\/v1"},{"issue":"1","key":"5909_CR105","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-024-01460-2","volume":"40","author":"MR Chowdhury","year":"2024","unstructured":"Chowdhury MR, Karamveer K, Tiwary BK, Nampoothiri NK, Erva RR, Deepa VS (2024) Integrated systems pharmacology, molecular docking, and MD simulations investigation elucidating the therapeutic mechanisms of BHD in Alzheimer\u2019s disease treatment. Metab Brain Dis 40(1):8. https:\/\/doi.org\/10.1007\/s11011-024-01460-2","journal-title":"Metab Brain Dis"},{"key":"5909_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413259","author":"MA Ejalonibu","year":"2021","unstructured":"Ejalonibu MA et al (2021) \u201cDrug discovery for Mycobacterium tuberculosis using structure-based computer-aided drug design approach,.\u201d Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222413259","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5909_CR107","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/s11030-022-10504-7","volume":"26","author":"R Swetha","year":"2022","unstructured":"Swetha R et al (2022) \u201cCombined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimer\u2019s disease,.\u201d Mol Divers 26(5):2877\u20132892. https:\/\/doi.org\/10.1007\/s11030-022-10504-7","journal-title":"Mol Divers"},{"issue":"10","key":"5909_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/biom14101330","volume":"14","author":"C Vicidomini","year":"2024","unstructured":"Vicidomini C, Fontanella F, D\u2019Alessandro T, Roviello GN (2024) A survey on computational methods in drug discovery for neurodegenerative diseases. Biomolecules 14(10):1330","journal-title":"Biomolecules"},{"key":"5909_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030703","author":"VD Mouchlis","year":"2020","unstructured":"Mouchlis VD, Melagraki G, Zacharia LC, Afantitis A (2020) Computer-aided drug design of \u03b2-secretase, \u03b3-secretase and anti-tau inhibitors for the discovery of novel Alzheimer\u2019s therapeutics. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21030703","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5909_CR110","doi-asserted-by":"publisher","DOI":"10.1002\/poc.4076","volume":"33","author":"MA Raza","year":"2020","unstructured":"Raza MA, Fatima K (2020) Molecular modeling approach for designing of amino\u2010derived anti\u2010Alzheimer agents: a computational study. J Phys Org Chem 33(10):e4076","journal-title":"J Phys Org Chem"},{"key":"5909_CR111","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4018\/979-8-3693-3605-2.ch005","volume-title":"AI-driven Alzheimer\u2019s disease detection and prediction","author":"V Tomar","year":"2024","unstructured":"Tomar V, Kumar A, Kate V, Kumar S, Gottumukkala P (2024) Advancements in Alzheimer\u2019s diagnosis: a comprehensive exploration of AI-powered diagnostic tools and software. AI-driven Alzheimer\u2019s disease detection and prediction. IGI Global, pp 69\u201380"},{"key":"5909_CR112","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4018\/979-8-3693-3629-8.ch013","volume-title":"Future of AI in biomedicine and biotechnology","author":"N Afrose","year":"2024","unstructured":"Afrose N, Chakraborty R, Hazra A, Bhowmick P, Bhowmick M (2024) AI-driven drug discovery and development. Future of AI in biomedicine and biotechnology. IGI Global Scientific Publishing, pp 259\u2013277"},{"key":"5909_CR113","doi-asserted-by":"crossref","unstructured":"Sathya K, Kannimuthu S (2024) Recent advances in AI-powered drug discovery: leveraging machine learning for mechanism of action prediction. in International Conference on Recent Advancements in Materials Science and Technology, Springer, pp. 363\u2013378.","DOI":"10.1007\/978-3-031-69966-5_35"},{"key":"5909_CR114","doi-asserted-by":"crossref","unstructured":"Mak KK, Pichika MR (2019) Artificial intelligence in drug development: present status and future prospects. Drug discovery today. Mar 1;24(3):773-80.","DOI":"10.1016\/j.drudis.2018.11.014"},{"key":"5909_CR115","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4018\/979-8-3693-2238-3.ch006","volume-title":"Approaches to human-centered AI in healthcare","author":"KP Rahate","year":"2024","unstructured":"Rahate KP, Sengar MS, Patel S (2024) Artificial intelligence in medical imaging by machine learning and deep learning. Approaches to human-centered AI in healthcare. IGI Global, pp 121\u2013159"},{"issue":"22","key":"5909_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223884","volume":"16","author":"P Garg","year":"2024","unstructured":"Garg P, Singhal G, Kulkarni P, Horne D, Salgia R, Singhal SS (2024) Artificial intelligence\u2013driven computational approaches in the development of anticancer drugs. Cancers (Basel). 16(22):3884","journal-title":"Cancers (Basel)."},{"issue":"1","key":"5909_CR117","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40203-022-00133-1","volume":"10","author":"N Lakra","year":"2022","unstructured":"Lakra N, Matore BW, Banjare P, Singh R, Singh J, Roy PP (2022) Pharmacophore based virtual screening of cholinesterase inhibitors: search of new potential drug candidates as antialzheimer agents. In Silico Pharmacol 10(1):18. https:\/\/doi.org\/10.1007\/s40203-022-00133-1","journal-title":"In Silico Pharmacol"},{"key":"5909_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ph16121645","author":"GO Mendes","year":"2023","unstructured":"Mendes GO et al (2023) Identification of potential multitarget compounds against Alzheimer\u2019s disease through pharmacophore-based virtual screening. Pharmaceuticals Basel. https:\/\/doi.org\/10.3390\/ph16121645","journal-title":"Pharmaceuticals Basel"},{"key":"5909_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/life13040952","author":"K Chidambaram","year":"2023","unstructured":"Chidambaram K (2023) Identification of BACE-1 inhibitors against Alzheimer\u2019s disease through E-pharmacophore-based virtual screening and molecular dynamics simulation studies: an insilco approach. Life (Basel). https:\/\/doi.org\/10.3390\/life13040952","journal-title":"Life (Basel)"},{"key":"5909_CR120","doi-asserted-by":"crossref","unstructured":"Patel S, Mishra PS, Rahaman SA, Kumar R, Makhdoomi MJ, Sheikh AA (2025) Integrating Small Molecules into Multimodal Treatment Strategies. InSmall Molecules in Neurodegeneration. Mar 13 (pp. 151-171). CRC Press.","DOI":"10.1201\/9781003520610-9"},{"key":"5909_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2022.108143","volume":"113","author":"H-C Wang","year":"2022","unstructured":"Wang H-C, Zhang Q-X, Zhao J, Wei N-N (2022) Molecular docking and molecular dynamics simulations studies on the protective and pathogenic roles of the amyloid-\u03b2 peptide between herpesvirus infection and Alzheimer\u2019s disease. J Mol Graph Model 113:108143. https:\/\/doi.org\/10.1016\/j.jmgm.2022.108143","journal-title":"J Mol Graph Model"},{"key":"5909_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25092071","author":"SS Ahmad","year":"2020","unstructured":"Ahmad SS, Sinha M, Ahmad K, Khalid M, Choi I (2020) Study of caspase 8 inhibition for the management of Alzheimer\u2019s disease: a molecular docking and dynamics simulation. Molecules (Basel). https:\/\/doi.org\/10.3390\/molecules25092071","journal-title":"Molecules (Basel)"},{"issue":"Suppl4","key":"5909_CR123","doi-asserted-by":"publisher","first-page":"S715","DOI":"10.33549\/physiolres.934765","volume":"70","author":"H Farghali","year":"2021","unstructured":"Farghali H, Kutinov\u00e1 Canov\u00e1 N, Arora M (2021) The potential applications of artificial intelligence in drug discovery and development. Physiol Res 70(Suppl4):S715\u2013S722. https:\/\/doi.org\/10.33549\/physiolres.934765","journal-title":"Physiol Res"},{"issue":"3","key":"5909_CR124","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/med.21764","volume":"41","author":"S Vatansever","year":"2021","unstructured":"Vatansever S et al (2021) Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: state-of-the-arts and future directions. Med Res Rev 41(3):1427\u20131473","journal-title":"Med Res Rev"},{"issue":"6","key":"5909_CR125","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2174\/18735592MTEzsMDMnz","volume":"22","author":"A Nayarisseri","year":"2021","unstructured":"Nayarisseri A (2021) Artificial intelligence, big data and machine learning approaches in precision medicine & drug discovery. Curr Drug Targets 22(6):631\u2013655","journal-title":"Curr Drug Targets"},{"issue":"7","key":"5909_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071916","volume":"15","author":"LK Vora","year":"2023","unstructured":"Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP (2023) Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics 15(7):1916","journal-title":"Pharmaceutics"},{"key":"5909_CR127","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ymeth.2015.04.021","volume":"83","author":"S Roy","year":"2015","unstructured":"Roy S, Kumar A, Baig MH, Masa\u0159\u00edk M, Provazn\u00edk I (2015) Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer\u2019s disease. Methods 83:105\u2013110. https:\/\/doi.org\/10.1016\/j.ymeth.2015.04.021","journal-title":"Methods"},{"key":"5909_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2025.108371","volume":"116","author":"N Kaur","year":"2025","unstructured":"Kaur N, Gupta S, Pal J, Bansal Y, Bansal G (2025) Design of BBB permeable BACE-1 inhibitor as potential drug candidate for Alzheimer disease: 2D-QSAR, molecular docking, ADMET, molecular dynamics, MMGBSA. Comput Biol Chem 116:108371. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108371","journal-title":"Comput Biol Chem"},{"issue":"15","key":"5909_CR129","doi-asserted-by":"publisher","first-page":"10581","DOI":"10.1021\/acs.jmedchem.1c00683","volume":"64","author":"X Li","year":"2021","unstructured":"Li X, Li X, Liu F, Li S, Shi D (2021) Rational multitargeted drug design strategy from the perspective of a medicinal chemist. J Med Chem 64(15):10581\u201310605","journal-title":"J Med Chem"},{"issue":"46","key":"5909_CR130","doi-asserted-by":"publisher","first-page":"13657","DOI":"10.1039\/D2SC03932J","volume":"13","author":"M Ramesh","year":"2022","unstructured":"Ramesh M, Govindaraju T (2022) Multipronged diagnostic and therapeutic strategies for Alzheimer\u2019s disease. Chem Sci 13(46):13657\u201313689","journal-title":"Chem Sci"},{"key":"5909_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26051202","author":"X Li","year":"2021","unstructured":"Li X, Yu Y, Tu Z (2021) Pyrazole scaffold synthesis, functionalization, and applications in Alzheimer\u2019s disease and Parkinson\u2019s disease treatment (2011\u20132020). Molecules (Basel). https:\/\/doi.org\/10.3390\/molecules26051202","journal-title":"Molecules (Basel)"},{"issue":"2","key":"5909_CR132","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.drudis.2018.11.012","volume":"24","author":"L Jing","year":"2019","unstructured":"Jing L et al (2019) \u201cContemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors,.\u201d Drug Discov Today 24(2):629\u2013635. https:\/\/doi.org\/10.1016\/j.drudis.2018.11.012","journal-title":"Drug Discov Today"},{"key":"5909_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111745","volume":"184","author":"S Sestito","year":"2019","unstructured":"Sestito S et al (2019) \u201cDesign and synthesis of H2S-donor hybrids: a new treatment for Alzheimer\u2019s disease?\u201d Eur J Med Chem 184:111745. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111745","journal-title":"Eur J Med Chem"},{"issue":"1","key":"5909_CR134","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/13543776.2021.1832463","volume":"31","author":"F Rombouts","year":"2021","unstructured":"Rombouts F, Kusakabe K, Hsiao C-C, Gijsen HJM (2021) Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). Expert Opin Ther Pat 31(1):25\u201352","journal-title":"Expert Opin Ther Pat"},{"issue":"3","key":"5909_CR135","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/18755348MTEyoMzEFz","volume":"25","author":"S Leyva-Ramos","year":"2021","unstructured":"Leyva-Ramos S, Cardoso-Ortiz J (2021) Recent developments in the synthesis of tetrazoles and their pharmacological relevance. Curr Org Chem 25(3):388\u2013403","journal-title":"Curr Org Chem"},{"issue":"3","key":"5909_CR136","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1021\/acs.jmedchem.0c01887","volume":"64","author":"A Beato","year":"2021","unstructured":"Beato A, Gori A, Boucherle B, Peuchmaur M, Haudecoeur R (2021) \u03b2-Carboline as a privileged scaffold for multitarget strategies in Alzheimer\u2019s disease therapy. J Med Chem 64(3):1392\u20131422","journal-title":"J Med Chem"},{"issue":"3","key":"5909_CR137","first-page":"423","volume":"12","author":"N Razzaghi-Asl","year":"2013","unstructured":"Razzaghi-Asl N, Ebadi A, Edraki N, Shahabipour S, Miri R (2013) Fragment-based binding efficiency indices in bioactive molecular design: a computational approach to BACE-1 inhibitors. Iran J Pharm Res 12(3):423","journal-title":"Iran J Pharm Res"},{"issue":"3","key":"5909_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030297","volume":"18","author":"MM de Souza","year":"2025","unstructured":"de Souza MM, Gini ALR, Moura JA, Scarim CB, Chin CM, Dos Santos JL (2025) Prodrug approach as a strategy to enhance drug permeability. Pharmaceuticals Basel 18(3):297","journal-title":"Pharmaceuticals Basel"},{"issue":"30","key":"5909_CR139","doi-asserted-by":"publisher","first-page":"26308","DOI":"10.1021\/acsomega.2c02130","volume":"7","author":"M Liang","year":"2022","unstructured":"Liang M et al (2022) Design, synthesis, and bioactivity of novel bifunctional small molecules for Alzheimer\u2019s disease. ACS Omega 7(30):26308\u201326315. https:\/\/doi.org\/10.1021\/acsomega.2c02130","journal-title":"ACS Omega"},{"key":"5909_CR140","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejmech.2019.02.053","volume":"168","author":"D Wang","year":"2019","unstructured":"Wang D et al (2019) Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 168:207\u2013220. https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.053","journal-title":"Eur J Med Chem"},{"key":"5909_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25040985","author":"S Chaves","year":"2020","unstructured":"Chaves S et al (2020) Design, synthesis, and in vitro evaluation of hydroxybenzimidazole-donepezil analogues as multitarget-directed ligands for the treatment of Alzheimer\u2019s disease. Molecules. https:\/\/doi.org\/10.3390\/molecules25040985","journal-title":"Molecules"},{"issue":"8","key":"5909_CR142","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s11814-025-00433-0","volume":"42","author":"H Karatas","year":"2025","unstructured":"Karatas H, Kul \u0130B, Aydin M, T\u00fcz\u00fcn B, Taslimi P, Kokbudak Z (2025) Alzheimer\u2019s disease drug design by synthesis, characterization, enzyme inhibition, in silico, SAR analysis and MM-GBSA analysis of Schiff bases derivatives. Korean J Chem Eng 42(8):1793\u20131811. https:\/\/doi.org\/10.1007\/s11814-025-00433-0","journal-title":"Korean J Chem Eng"},{"issue":"9","key":"5909_CR143","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/17460441.2025.2532688","volume":"20","author":"C Mallick","year":"2025","unstructured":"Mallick C, Banerjee S, Amin SA (2025) Novel insights into structure\u2013activity relationships of kynurenine 3-monooxygenase inhibitors (KMOis) with emphasis on chemical space, activity landscape exploration. Expert Opin Drug Discov 20(9):1209\u20131221","journal-title":"Expert Opin Drug Discov"},{"key":"5909_CR144","unstructured":"Verma VS (2025) Development of multi-target directed ligands for neurodegenerative disorders: a medicinal chemistry approach.\u00a0Interconnected J Chem Pharm Sci\u00a049\u201365"},{"issue":"4","key":"5909_CR145","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70131","volume":"13","author":"MS Hossain","year":"2025","unstructured":"Hossain MS, Hussain MH (2025) \u201cMulti\u2010target drug design in Alzheimer\u2019s disease treatment: emerging technologies, advantages, challenges, and limitations,.\u201d Pharmacol. Res. Perspect. 13(4):e70131","journal-title":"Pharmacol. Res. Perspect."},{"key":"5909_CR146","doi-asserted-by":"publisher","unstructured":"Patil VM, Masand N, Gautam V, Kaushik S, Wu D (2023) Multi-target-directed ligand approach in anti-Alzheimer\u2019s drug discovery BT - Deciphering drug targets for Alzheimer\u2019s disease,\u201d D. Kumar, V. M. Patil, D. Wu, and N. Thorat, Eds., Singapore: Springer Nature Singapore, pp. 285\u2013319. https:\/\/doi.org\/10.1007\/978-981-99-2657-2_13.","DOI":"10.1007\/978-981-99-2657-2_13"},{"key":"5909_CR147","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00969","author":"TB Callis","year":"2022","unstructured":"Callis TB, Garrett TR, Montgomery AP, Danon JJ, Kassiou M (2022) Recent scaffold hopping applications in central nervous system drug discovery. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00969","journal-title":"J Med Chem"},{"issue":"22","key":"5909_CR148","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1021\/acs.jmedchem.0c00829","volume":"63","author":"TT Talele","year":"2020","unstructured":"Talele TT (2020) \u201cOpportunities for tapping into three-dimensional chemical space through a quaternary carbon,.\u201d J. Med. Chem. 63(22):13291\u201313315. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00829","journal-title":"J. Med. Chem."},{"issue":"8","key":"5909_CR149","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41570-024-00623-0","volume":"8","author":"J Tsien","year":"2024","unstructured":"Tsien J, Hu C, Merchant RR, Qin T (2024) \u201cThree-dimensional saturated C(sp3)-rich bioisosteres for benzene,.\u201d Nat. Rev. Chem. 8(8):605\u2013627. https:\/\/doi.org\/10.1038\/s41570-024-00623-0","journal-title":"Nat. Rev. Chem."},{"issue":"17","key":"5909_CR150","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.1080\/07391102.2022.2134212","volume":"41","author":"FA Sofi","year":"2023","unstructured":"Sofi FA, Tabassum N (2023) \u201cNatural product inspired leads in the discovery of anticancer agents: an update,.\u201d J. Biomol. Struct. Dyn. 41(17):8605\u20138628","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"5909_CR151","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1021\/acs.joc.1c02698","volume":"87","author":"V Srinivasulu","year":"2022","unstructured":"Srinivasulu V et al (2022) Stereodivergent complexity-to-diversity strategy en route to the synthesis of nature-inspired Skeleta. J Org Chem 87(2):1377\u20131397","journal-title":"J Org Chem"},{"key":"5909_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09742-0","author":"C Ahn","year":"2025","unstructured":"Ahn C, Gomez A, Hartmann MA, White MC (2025) Selective methylene oxidation in \u03b1,\u03b2-unsaturated carbonyl natural products. Nature. https:\/\/doi.org\/10.1038\/s41586-025-09742-0","journal-title":"Nature"},{"issue":"23","key":"5909_CR153","doi-asserted-by":"publisher","first-page":"20723","DOI":"10.1021\/acs.jmedchem.4c02736","volume":"67","author":"SB Bharate","year":"2024","unstructured":"Bharate SB, Lindsley CW (2024) Natural products driven medicinal chemistry. J Med Chem 67(23):20723\u201320730. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02736","journal-title":"J Med Chem"},{"issue":"2","key":"5909_CR154","first-page":"84","volume":"4","author":"H Bechlem","year":"2025","unstructured":"Bechlem H, Bougandoura AD, Bahi M, Benouchenne D (2025) Next-generation anticancer agents from the Amaryllidaceae family: design, optimization, and nano-delivery strategies for clinical translation. J Mol Pharm Sci 4(2):84\u201397","journal-title":"J Mol Pharm Sci"},{"key":"5909_CR155","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/B978-0-443-24126-0.00008-1","volume-title":"Quinone-based compounds in drug discovery","author":"S Jadala","year":"2025","unstructured":"Jadala S (2025) Quinone-based materials in immunotherapy. Quinone-based compounds in drug discovery. Elsevier, pp 137\u2013150"},{"issue":"2","key":"5909_CR156","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2174\/1570159X18666201111110136","volume":"19","author":"S Singh","year":"2021","unstructured":"Singh S et al (2021) Naturally inspired pyrimidines analogues for Alzheimer\u2019s disease. Curr Neuropharmacol 19(2):136\u2013151","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"5909_CR157","doi-asserted-by":"publisher","DOI":"10.1002\/sstr.202100228","volume":"3","author":"B Wijerathne","year":"2022","unstructured":"Wijerathne B, Liao T, Ostrikov K, Sun Z (2022) Bioinspired robust mechanical properties for advanced materials. Small Struct 3(9):2100228","journal-title":"Small Struct"},{"issue":"5","key":"5909_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054399","volume":"24","author":"R Vrabec","year":"2023","unstructured":"Vrabec R, Blunden G, Cahl\u00edkov\u00e1 L (2023) Natural alkaloids as multi-target compounds towards factors implicated in Alzheimer\u2019s disease. Int J Mol Sci 24(5):4399","journal-title":"Int J Mol Sci"},{"issue":"57","key":"5909_CR159","doi-asserted-by":"publisher","first-page":"45853","DOI":"10.1039\/C5RA05069C","volume":"5","author":"MM Kasprzak","year":"2015","unstructured":"Kasprzak MM, Erxleben A, Ochocki J (2015) Properties and applications of flavonoid metal complexes. RSC Adv 5(57):45853\u201345877","journal-title":"RSC Adv"},{"issue":"3","key":"5909_CR160","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1021\/acs.jmedchem.4c03049","volume":"68","author":"Z Li","year":"2025","unstructured":"Li Z, Zhang Z, Yu B (2025) Unlocking the therapeutic potential of natural products for Alzheimer\u2019s disease. J Med Chem 68(3):2377\u20132402. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c03049","journal-title":"J Med Chem"},{"key":"5909_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020360","author":"P Tiwari","year":"2022","unstructured":"Tiwari P, Bae H (2022) Endophytic fungi: key insights, emerging prospects, and challenges in natural product drug discovery. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10020360","journal-title":"Microorganisms"},{"issue":"1","key":"5909_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35157-w","volume":"13","author":"M-L Charpignon","year":"2022","unstructured":"Charpignon M-L et al (2022) Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia. Nat Commun 13(1):7652. https:\/\/doi.org\/10.1038\/s41467-022-35157-w","journal-title":"Nat Commun"},{"issue":"1","key":"5909_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202401905","volume":"22","author":"X Sun","year":"2025","unstructured":"Sun X et al (2025) Terpestacin and its derivatives: bioactivities and syntheses. Chem Biodivers 22(1):e202401905","journal-title":"Chem Biodivers"},{"key":"5909_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121618","author":"P Stamou","year":"2024","unstructured":"Stamou P et al (2024) Anti-inflammatory activity of the major triterpenic acids of Chios Mastic Gum and their semi-synthetic analogues. Biomolecules. https:\/\/doi.org\/10.3390\/biom14121618","journal-title":"Biomolecules"},{"issue":"13","key":"5909_CR165","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1080\/14786419.2022.2037084","volume":"37","author":"M Singh","year":"2023","unstructured":"Singh M et al (2023) Isolation of phytochemicals from Dolichandrone atrovirens followed by semisynthetic modification of ixoside via azomethine ylide cycloaddition; Computational approach towards chemo-selection. Nat Prod Res 37(13):2215\u20132224","journal-title":"Nat Prod Res"},{"issue":"1","key":"5909_CR166","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8056462","volume":"2023","author":"M Hatami","year":"2023","unstructured":"Hatami M, Mortazavi M, Baseri Z, Khani B, Rahimi M, Babaei S (2023) Antioxidant compounds in the treatment of Alzheimer\u2019s disease: natural, hybrid, and synthetic products. Evid Based Complement Altern Med 2023(1):8056462","journal-title":"Evid Based Complement Altern Med"},{"key":"5909_CR167","doi-asserted-by":"crossref","unstructured":"Nudelman A (2024) Hybrid\/chimera drugs-part 1-drug hybrids affecting diseases of the central nervous system. Current Medicinal Chemistry. Oct 28.","DOI":"10.2174\/0109298673305662240702071354"},{"issue":"7","key":"5909_CR168","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70035","volume":"358","author":"AE Shaaban","year":"2025","unstructured":"Shaaban AE, Ali AR, Ayyad SN, Badria FA (2025) Novel purine\u2010based natural products as inhibitors of cholinesterases and monoamine oxidases presenting potential multitarget therapeutics tackling Alzheimer\u2019s disease. Arch Pharm Weinheim 358(7):e70035","journal-title":"Arch Pharm Weinheim"},{"key":"5909_CR169","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050545","author":"A Sampietro","year":"2022","unstructured":"Sampietro A, P\u00e9rez-Areales FJ, Mart\u00ednez P, Arce EM, Galdeano C, Mu\u00f1oz-Torrero D (2022) Unveiling the multitarget anti-Alzheimer drug discovery landscape: a bibliometric analysis. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph15050545","journal-title":"Pharmaceuticals"},{"key":"5909_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/life14121555","author":"R Cacabelos","year":"2024","unstructured":"Cacabelos R, Mart\u00ednez-Iglesias O, Cacabelos N, Carrera I, Corzo L, Naidoo V (2024) Therapeutic options in Alzheimer\u2019s disease: from classic acetylcholinesterase inhibitors to multi-target drugs with pleiotropic activity. Life Basel. https:\/\/doi.org\/10.3390\/life14121555","journal-title":"Life Basel"},{"key":"5909_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/ph15121560","author":"SL Cheong","year":"2022","unstructured":"Cheong SL et al (2022) Current pharmacotherapy and multi-target approaches for Alzheimer\u2019s disease. Pharmaceuticals Basel. https:\/\/doi.org\/10.3390\/ph15121560","journal-title":"Pharmaceuticals Basel"},{"key":"5909_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.980141","volume-title":"Multi-target directed ligands for the treatment of cancer","author":"M Brindisi","year":"2022","unstructured":"Brindisi M, Kessler SM, Kumar V, Zwergel C (2022) Multi-target directed ligands for the treatment of cancer. Frontiers Media SA"},{"issue":"11","key":"5909_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/ph18111685","volume":"18","author":"M Almaghrabi","year":"2025","unstructured":"Almaghrabi M (2025) Multitarget-directed ligands for Alzheimer\u2019s disease: recent novel MTDLs and mechanistic insights. Pharmaceuticals Basel 18(11):1685","journal-title":"Pharmaceuticals Basel"},{"issue":"1","key":"5909_CR174","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cmdc.202000484","volume":"16","author":"R Perone","year":"2021","unstructured":"Perone R et al (2021) Turning Donepezil into a multi\u2010target\u2010directed ligand through a merging strategy. ChemMedChem 16(1):187\u2013198","journal-title":"ChemMedChem"},{"key":"5909_CR175","doi-asserted-by":"crossref","unstructured":"Lin J, Pang Y, Xia Y, Chen Z, Luo J (2020) Tuigan: learning versatile image-to-image translation with two unpaired images. In European conference on computer vision, Springer, pp. 18\u201335.","DOI":"10.1007\/978-3-030-58548-8_2"},{"issue":"9","key":"5909_CR176","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41579-020-0372-5","volume":"18","author":"AJ Lopatkin","year":"2020","unstructured":"Lopatkin AJ, Collins JJ (2020) Predictive biology: modelling, understanding and harnessing microbial complexity. Nat Rev Microbiol 18(9):507\u2013520","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"5909_CR177","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70273","volume":"21","author":"KB Yenkoyan","year":"2025","unstructured":"Yenkoyan KB et al (2025) Experimental modeling of Alzheimer\u2019s disease: translational lessons from cross\u2010taxon analyses. Alzheimers Dement 21(5):e70273","journal-title":"Alzheimers Dement"},{"issue":"5","key":"5909_CR178","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s43587-023-00402-4","volume":"3","author":"P Padmanabhan","year":"2023","unstructured":"Padmanabhan P, G\u00f6tz J (2023) Clinical relevance of animal models in aging-related dementia research. Nat Aging 3(5):481\u2013493","journal-title":"Nat Aging"},{"issue":"1","key":"5909_CR179","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41551-021-00819-5","volume":"6","author":"C Xie","year":"2022","unstructured":"Xie C et al (2022) Amelioration of Alzheimer\u2019s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat Biomed Eng 6(1):76\u201393","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"5909_CR180","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5467498","volume":"2022","author":"A Tanas","year":"2022","unstructured":"Tanas A et al (2022) In vitro and in vivo neuroprotective effects of sarcosine. Biomed Res Int 2022(1):5467498","journal-title":"Biomed Res Int"},{"key":"5909_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153453","volume":"82","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xian Y-F, Loo S, Chan WY, Liu L, Lin Z-X (2021) Anti-atopic dermatitis effects of Dictamni cortex: studies on in vitro and in vivo experimental models. Phytomedicine 82:153453","journal-title":"Phytomedicine"},{"issue":"18","key":"5909_CR182","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.3390\/ijms21186664","volume":"21","author":"P Maiti","year":"2020","unstructured":"Maiti P, Manna J, Burch ZN, Flaherty DB, Larkin JD, Dunbar GL (2020) RETRACTED: ameliorative properties of boronic compounds in in vitro and in vivo models of Alzheimer\u2019s disease. Int J Mol Sci 21(18):6664","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5909_CR183","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1111\/ejn.15565","volume":"56","author":"K Celik Topkara","year":"2022","unstructured":"Celik Topkara K, Kilinc E, Cetinkaya A, Saylan A, Demir S (2022) Therapeutic effects of carvacrol on beta\u2010amyloid\u2010induced impairments in in vitro and in vivo models of Alzheimer\u2019s disease. Eur J Neurosci 56(9):5714\u20135726","journal-title":"Eur J Neurosci"},{"issue":"2","key":"5909_CR184","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s12015-021-10254-3","volume":"18","author":"M Barak","year":"2022","unstructured":"Barak M et al (2022) Human iPSC-derived neural models for studying Alzheimer\u2019s disease: from neural stem cells to cerebral organoids. Stem Cell Rev Rep 18(2):792\u2013820. https:\/\/doi.org\/10.1007\/s12015-021-10254-3","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"5909_CR185","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02407-z","volume":"19","author":"D Pilat","year":"2022","unstructured":"Pilat D et al (2022) MT5-MMP promotes neuroinflammation, neuronal excitability and A\u03b2 production in primary neuron\/astrocyte cultures from the 5xFAD mouse model of Alzheimer\u2019s disease. J Neuroinflammation 19(1):65. https:\/\/doi.org\/10.1186\/s12974-022-02407-z","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5909_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03732-1","volume":"15","author":"MS Choe","year":"2024","unstructured":"Choe MS et al (2024) Simple modeling of familial Alzheimer\u2019s disease using human pluripotent stem cell-derived cerebral organoid technology. Stem Cell Res Ther 15(1):118. https:\/\/doi.org\/10.1186\/s13287-024-03732-1","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5909_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s42826-023-00184-1","volume":"39","author":"R Dhapola","year":"2023","unstructured":"Dhapola R, Kumari S, Sharma P, HariKrishnaReddy D (2023) Insight into the emerging and common experimental in-vivo models of Alzheimer\u2019s disease. Lab Anim Res 39(1):33. https:\/\/doi.org\/10.1186\/s42826-023-00184-1","journal-title":"Lab Anim Res"},{"key":"5909_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114105","volume":"158","author":"IG Ju","year":"2023","unstructured":"Ju IG et al (2023) Protective effects of CCL01 against A\u03b2-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer\u2019s disease. Biomed Pharmacother 158:114105. https:\/\/doi.org\/10.1016\/j.biopha.2022.114105","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5909_CR189","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/0118715249293642240522054929","volume":"25","author":"S Sinha","year":"2025","unstructured":"Sinha S et al (2025) \u201cResearch on Alzheimer\u2019s disease (AD) involving the use of in vivo and in vitro models and mechanisms,.\u201d Cent Nerv Syst Agents Med Chem 25(2):123\u2013142","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"4","key":"5909_CR190","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/1573412919666230406100948","volume":"19","author":"MH Shahrajabian","year":"2023","unstructured":"Shahrajabian MH, Sun W (2023) Survey on multi-omics, and multi-omics data analysis, integration and application. Curr Pharm Anal 19(4):267\u2013281","journal-title":"Curr Pharm Anal"},{"key":"5909_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.831866","volume":"13","author":"AJ Noble","year":"2022","unstructured":"Noble AJ et al (2022) \u201cA final frontier in environment-genome interactions? integrated, multi-omic approaches to predictions of non-communicable disease risk,.\u201d Front Genet 13:831866","journal-title":"Front Genet"},{"issue":"5","key":"5909_CR192","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10462-024-10768-5","volume":"57","author":"I Ghebrehiwet","year":"2024","unstructured":"Ghebrehiwet I, Zaki N, Damseh R, Mohamad MS (2024) Revolutionizing personalized medicine with generative AI: a systematic review. Artif Intell Rev 57(5):128","journal-title":"Artif Intell Rev"},{"issue":"2","key":"5909_CR193","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1021\/acsptsci.3c00231","volume":"7","author":"P Bathla","year":"2024","unstructured":"Bathla P, Mujawar A, De A, Sandanaraj BS (2024) Development of noninvasive activity-based protein profiling-bioluminescence resonance energy transfer platform technology enables target engagement studies with absolute specificity in living systems. ACS Pharmacol Transl Sci 7(2):375\u2013383. https:\/\/doi.org\/10.1021\/acsptsci.3c00231","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"5909_CR194","doi-asserted-by":"publisher","first-page":"10347","DOI":"10.1038\/s41467-024-54415-7","volume":"15","author":"NCK Valerie","year":"2024","unstructured":"Valerie NCK et al (2024) Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM. Nat Commun 15(1):10347. https:\/\/doi.org\/10.1038\/s41467-024-54415-7","journal-title":"Nat Commun"},{"issue":"1","key":"5909_CR195","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s44328-025-00040-3","volume":"2","author":"KD Mac","year":"2025","unstructured":"Mac KD, Su J (2025) Optical biosensors for diagnosing neurodegenerative diseases. npj Biosensing 2(1):20.https:\/\/doi.org\/10.1038\/s44328-025-00040-3","journal-title":"npj Biosensing"},{"issue":"1","key":"5909_CR196","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12038","volume":"6","author":"SJ Sukoff Rizzo","year":"2020","unstructured":"Sukoff Rizzo SJ et al (2020) Improving preclinical to clinical translation in Alzheimer\u2019s disease research. Alzheimers Dement N Y 6(1):e12038","journal-title":"Alzheimers Dement N Y"},{"issue":"1","key":"5909_CR197","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20(1):165","journal-title":"J Neuroinflammation"},{"key":"5909_CR198","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043866","author":"Y El Ouaamari","year":"2023","unstructured":"El Ouaamari Y, den Bos J, Willekens B, Cools N, Wens I (2023) Neurotrophic factors as regenerative therapy for neurodegenerative diseases: Current status, challenges and future perspectives. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24043866","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5909_CR199","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12295","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings J et al (2022) Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimer\u2019s Dement Transl Res Clin Interv 8(1):e12295","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"issue":"3","key":"5909_CR200","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/14712598.2025.2463963","volume":"25","author":"F Panza","year":"2025","unstructured":"Panza F et al (2025) Successes and failures: the latest advances in the clinical development of amyloid\u2013\u03b2\u2013targeting monoclonal antibodies for treating Alzheimer\u2019s disease. Expert Opin Biol Ther 25(3):275\u2013283","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"5909_CR201","doi-asserted-by":"publisher","first-page":"e70382","DOI":"10.1096\/fj.202402622R","volume":"39","author":"D Muramatsu","year":"2025","unstructured":"Muramatsu D et al (2025) ALZ\u2010801 prevents amyloid \u03b2\u2010protein assembly and reduces cytotoxicity: a preclinical experimental study. FASEB J 39(3):e70382. https:\/\/doi.org\/10.1096\/fj.202402622R","journal-title":"FASEB J"},{"issue":"38","key":"5909_CR202","doi-asserted-by":"publisher","first-page":"2307971","DOI":"10.1002\/advs.202307971","volume":"11","author":"R Li","year":"2024","unstructured":"Li R et al (2024) The brain\u2013gut\u2013bone axis in neurodegenerative diseases: insights, challenges, and future prospects. Adv Sci 11(38):2307971","journal-title":"Adv Sci"},{"key":"5909_CR203","doi-asserted-by":"crossref","unstructured":"Wang HY, Pei Z, Lee KC, Nikolov B, Doehner T, Puente J, Friedmann N, Burns LH (2023) Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer\u2019s disease patient lymphocytes. Frontiers in Aging. Jun 29;4:1175601.","DOI":"10.3389\/fragi.2023.1175601"},{"key":"5909_CR204","volume-title":"Validating novel neurodegenerative targets for future dementia therapeutics","author":"E Murphy","year":"2025","unstructured":"Murphy E (2025) Validating novel neurodegenerative targets for future dementia therapeutics. Taylor & Francis"},{"issue":"3","key":"5909_CR205","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s43441-025-00763-5","volume":"59","author":"H Hatcher","year":"2025","unstructured":"Hatcher H, Stankeviciute S, Learn C, Qu AX (2025) Regulatory, translational, and operational considerations for the incorporation of biomarkers in drug development. Ther Innov Regul Sci 59(3):519\u2013526","journal-title":"Ther Innov Regul Sci"},{"issue":"8","key":"5909_CR206","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083805","volume":"22","author":"K Rihawi","year":"2021","unstructured":"Rihawi K et al (2021) \u201cTumor-associated macrophages and inflammatory microenvironment in gastric cancer: novel translational implications,.\u201d Int J Mol Sci 22(8):3805","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5909_CR207","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41423-023-00992-4","volume":"20","author":"P Facheris","year":"2023","unstructured":"Facheris P, Jeffery J, Del Duca E, Guttman-Yassky E (2023) The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment. Cell Mol Immunol 20(5):448\u2013474","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"5909_CR208","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12385","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2023) Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement Transl Res Clin Interv 9(2):e12385","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"issue":"15","key":"5909_CR209","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","volume":"83","author":"JL Cummings","year":"2023","unstructured":"Cummings JL, Osse AML, Kinney JW (2023) Alzheimer\u2019s disease: novel targets and investigational drugs for disease modification. Drugs 83(15):1387\u20131408","journal-title":"Drugs"},{"key":"5909_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17081041","author":"H-M Yang","year":"2025","unstructured":"Yang H-M (2025) \u201cOvercoming the blood\u2013brain barrier: advanced strategies in targeted drug delivery for neurodegenerative diseases,.\u201d Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics17081041","journal-title":"Pharmaceutics"},{"issue":"1","key":"5909_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01915-3","volume":"29","author":"I Iqbal","year":"2024","unstructured":"Iqbal I et al (2024) \u201cAlzheimer\u2019s disease and drug delivery across the blood\u2013brain barrier: approaches and challenges,.\u201d Eur J Med Res 29(1):313","journal-title":"Eur J Med Res"},{"issue":"30","key":"5909_CR212","doi-asserted-by":"publisher","first-page":"32606","DOI":"10.1021\/acsomega.5c02206","volume":"10","author":"E Kirit","year":"2025","unstructured":"Kirit E, Gokce C, Altun B, Yilmazer A (2025) \u201cNanotherapeutic strategies for overcoming the blood\u2013brain barrier: applications in disease modeling and drug delivery,.\u201d ACS Omega 10(30):32606\u201332625. https:\/\/doi.org\/10.1021\/acsomega.5c02206","journal-title":"ACS Omega"},{"key":"5909_CR213","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040835","author":"P Poudel","year":"2022","unstructured":"Poudel P, Park S (2022) \u201cRecent advances in the treatment of Alzheimer\u2019s disease using nanoparticle-based drug delivery systems,.\u201d Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14040835","journal-title":"Pharmaceutics"},{"key":"5909_CR214","doi-asserted-by":"publisher","unstructured":"Dighe S, Jog S, Momin M, Sawarkar S, Omri A (2024) Intranasal drug delivery by nanotechnology: advances in and challenges for Alzheimer\u2019s disease management.\u00a0Pharmaceutics\u00a016\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics16010058.","DOI":"10.3390\/pharmaceutics16010058"},{"key":"5909_CR215","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020335","author":"A Arafah","year":"2023","unstructured":"Arafah A et al (2023) The future of precision medicine in the cure of Alzheimer\u2019s disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11020335","journal-title":"Biomedicines"},{"key":"5909_CR216","doi-asserted-by":"publisher","unstructured":"Perna G, Spiti A, Torti T, Dacc\u00f2 S, Caldirola D (2024) Biomarker-guided tailored therapy in major depression BT - Recent advances and challenges in the treatment of major depressive disorder,\u201d Y.-K. Kim, Ed., Singapore: Springer Nature Singapore, pp. 379\u2013400. https:\/\/doi.org\/10.1007\/978-981-97-4402-2_19.","DOI":"10.1007\/978-981-97-4402-2_19"},{"key":"5909_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13113098","author":"G Tondo","year":"2024","unstructured":"Tondo G et al (2024) Novel therapeutic strategies in Alzheimer\u2019s disease: pitfalls and challenges of anti-amyloid therapies and beyond. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13113098","journal-title":"J Clin Med"},{"issue":"1","key":"5909_CR218","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"A-C Raulin","year":"2022","unstructured":"Raulin A-C, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu C-C (2022) ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener 17(1):72. https:\/\/doi.org\/10.1186\/s13024-022-00574-4","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5909_CR219","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13195-020-00670-x","volume":"12","author":"M Guo","year":"2020","unstructured":"Guo M, Yin Z, Chen F, Lei P (2020) Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer\u2019s disease. Alzheimers Res Ther 12(1):109. https:\/\/doi.org\/10.1186\/s13195-020-00670-x","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"5909_CR220","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00474-z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai B et al (2021) Proteomic landscape of Alzheimer\u2019s disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener 16(1):55. https:\/\/doi.org\/10.1186\/s13024-021-00474-z","journal-title":"Mol Neurodegener"},{"key":"5909_CR221","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061548","author":"MN Mithaiwala","year":"2021","unstructured":"Mithaiwala MN, Santana-Coelho D, Porter GA, O\u2019Connor JC (2021) Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications. Cells. https:\/\/doi.org\/10.3390\/cells10061548","journal-title":"Cells"},{"key":"5909_CR222","doi-asserted-by":"publisher","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG (2020) Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis 12:1179573520907397","journal-title":"J Cent Nerv Syst Dis"},{"key":"5909_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120861","volume":"306","author":"S Asher","year":"2022","unstructured":"Asher S, Priefer R (2022) Alzheimer\u2019s disease failed clinical trials. Life Sci 306:120861","journal-title":"Life Sci"},{"issue":"2","key":"5909_CR224","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12737","volume":"19","author":"JB Langbaum","year":"2023","unstructured":"Langbaum JB et al (2023) Recommendations to address key recruitment challenges of Alzheimer\u2019s disease clinical trials. Alzheimer\u2019s Dement 19(2):696\u2013707","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"5909_CR225","first-page":"5380346","volume":"2020","author":"AE Oxford","year":"2020","unstructured":"Oxford AE, Stewart ES, Rohn TT (2020) Clinical trials in Alzheimer\u2019s disease: a hurdle in the path of remedy. Int J Alzheimers Dis 2020(1):5380346","journal-title":"Int J Alzheimers Dis"},{"issue":"3","key":"5909_CR226","doi-asserted-by":"publisher","first-page":"388","DOI":"10.14283\/jpad.2022.50","volume":"9","author":"R Raman","year":"2022","unstructured":"Raman R et al (2022) Tackling a major deficiency of diversity in Alzheimer\u2019s disease therapeutic trials: an CTAD task force report. J Prev Alzheimers Dis 9(3):388\u2013392","journal-title":"J Prev Alzheimers Dis"},{"key":"5909_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101379","author":"F Cheng","year":"2024","unstructured":"Cheng F et al (2024) Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer\u2019s disease. Cell Rep Med. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101379","journal-title":"Cell Rep Med"},{"key":"5909_CR228","doi-asserted-by":"publisher","DOI":"10.3390\/s23094184","author":"AG Vrahatis","year":"2023","unstructured":"Vrahatis AG, Skolariki K, Krokidis MG, Lazaros K, Exarchos TP, Vlamos P (2023) Revolutionizing the early detection of Alzheimer\u2019s disease through non-invasive biomarkers: the role of artificial intelligence and deep learning. Sensors Basel. https:\/\/doi.org\/10.3390\/s23094184","journal-title":"Sensors Basel"},{"issue":"6","key":"5909_CR229","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/ene.14174","volume":"27","author":"MT Ferretti","year":"2020","unstructured":"Ferretti MT et al (2020) Sex and gender differences in Alzheimer\u2019s disease: current challenges and implications for clinical practice: position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology. Eur J Neurol 27(6):928\u2013943","journal-title":"Eur J Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05909-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:13:31Z","timestamp":1778591611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05909-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":229,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5909"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05909-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"621"}}